메뉴 건너뛰기




Volumn 1245, Issue , 2012, Pages 117-121

A sensitive and accurate liquid chromatography-tandem mass spectrometry method for quantitative determination of the novel hepatitis C NS5A inhibitor BMS-790052 (daclastasvir) in human plasma and urine

Author keywords

BMS 790052; Human plasma and urine; LC MS MS; LLE

Indexed keywords

BMS-790052; CLINICAL STUDY; GEOMETRIC MEAN; HEPATITIS C; HUMAN PLASMAS; HUMAN URINE; INTER-ASSAY PRECISION; INTERNAL STANDARDS; INTRA-ASSAY PRECISION; LC-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID-LIQUID EXTRACTION; LLE; METHYL-T-BUTYL ETHERS; MULTIPLE-REACTION MONITORING MODES; POSITIVELY CHARGED IONS; QUANTITATIVE DETERMINATIONS; STANDARD CURVES;

EID: 84861963822     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2012.05.028     Document Type: Article
Times cited : (34)

References (6)
  • 6
    • 0003484310 scopus 로고    scopus 로고
    • Guidance for Industry: Bioanalytical Method Validation
    • Guidance for Industry: Bioanalytical Method Validation, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.